News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
116,235 Results
Type
Article (7060)
Company Profile (13)
Press Release (109162)
Section
Business (30189)
Career Advice (213)
Deals (6739)
Drug Delivery (8)
Drug Development (16250)
Employer Resources (20)
FDA (3847)
Job Trends (2773)
News (55471)
Policy (4271)
Tag
2024 BioMidwest Digital (1)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (4)
2026 Genetown Elite (1)
Academia (472)
Adcomms (3)
Allergies (10)
Alliances (7004)
ALS (9)
Alzheimer's disease (526)
Antibody-drug conjugate (ADC) (9)
Approvals (3885)
Artificial intelligence (80)
Autoimmune disease (2)
Automation (3)
Bankruptcy (50)
Best Places to Work (2650)
BIOSECURE Act (1)
Biosimilars (23)
Biotechnology (11)
Bladder cancer (16)
Brain cancer (7)
Breast cancer (85)
Cancer (578)
Cardiovascular disease (35)
Career advice (180)
Career pathing (2)
CAR-T (13)
Cell therapy (52)
Cervical cancer (4)
Clinical research (13593)
Collaboration (153)
Compensation (404)
Complete response letters (1)
COVID-19 (560)
CRISPR (4)
C-suite (34)
Cystic fibrosis (20)
Data (590)
Decentralized trials (1)
Depression (10)
Diabetes (60)
Diagnostics (1592)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (6)
Drug discovery (22)
Drug pricing (4)
Drug shortages (1)
Duchenne muscular dystrophy (8)
Earnings (16061)
Editorial (3)
Employer branding (3)
Employer resources (20)
Events (15745)
Executive appointments (110)
FDA (4133)
Featured Employer (8)
Frontotemporal dementia (1)
Funding (138)
Gene editing (10)
Generative AI (6)
Gene therapy (40)
GLP-1 (139)
Government (595)
Guidances (9)
Healthcare (4011)
Huntington's disease (5)
IgA nephropathy (2)
Immunology and inflammation (22)
Indications (12)
Infectious disease (577)
Inflammatory bowel disease (34)
Influenza (7)
Intellectual property (7)
Interviews (30)
IPO (4090)
IRA (2)
Job creations (317)
Job search strategy (156)
Kidney cancer (6)
Labor market (6)
Layoffs (72)
Leadership (3)
Legal (567)
Liver cancer (24)
Lung cancer (108)
Lymphoma (46)
Management (6)
Manufacturing (42)
MASH (16)
Medical device (3106)
Medtech (3107)
Mergers & acquisitions (2799)
Metabolic disorders (115)
Multiple sclerosis (23)
NASH (7)
Neurodegenerative disease (18)
Neuropsychiatric disorders (3)
Neuroscience (633)
NextGen: Class of 2025 (957)
Non-profit (775)
Northern California (575)
Now hiring (1)
Obesity (39)
Opinion (29)
Ovarian cancer (13)
Pain (13)
Pancreatic cancer (20)
Parkinson's disease (30)
Partnered (3)
Patents (15)
Patient recruitment (15)
Peanut (7)
People (6126)
Pharmaceutical (3)
Phase I (3370)
Phase II (5860)
Phase III (5536)
Pipeline (246)
Podcasts (1)
Policy (7)
Postmarket research (627)
Preclinical (1211)
Press Release (5)
Prostate cancer (33)
Psychedelics (4)
Radiopharmaceuticals (144)
Rare diseases (57)
Real estate (696)
Recruiting (8)
Regulatory (3509)
Reports (16)
Research institute (434)
Resumes & cover letters (26)
Rett syndrome (1)
RSV (4)
Schizophrenia (18)
Series A (17)
Series B (11)
Sickle cell disease (8)
Southern California (464)
Special edition (8)
Sponsored (3)
Startups (400)
Supply chain (3)
The Weekly (1)
United States (4840)
Vaccines (198)
Venture capitalists (6)
Weight loss (10)
Women's health (1)
Date
Today (17)
Last 7 days (163)
Last 30 days (751)
Last 365 days (8273)
2025 (1676)
2024 (8234)
2023 (8775)
2022 (11552)
2021 (11340)
2020 (9327)
2019 (8195)
2018 (5931)
2017 (5706)
2016 (4996)
2015 (5939)
2014 (4314)
2013 (3520)
2012 (3875)
2011 (3992)
2010 (3528)
Location
Africa (98)
Alabama (3)
Alaska (1)
Arizona (26)
Arkansas (3)
Asia (6691)
Australia (1186)
California (1222)
Canada (358)
China (72)
Colorado (56)
Connecticut (67)
Delaware (58)
Europe (17262)
Florida (202)
Georgia (37)
Idaho (11)
Illinois (126)
India (7)
Indiana (86)
Iowa (2)
Japan (39)
Kansas (18)
Kentucky (7)
Maine (12)
Maryland (145)
Massachusetts (1011)
Michigan (39)
Minnesota (65)
Mississippi (1)
Missouri (18)
Nebraska (2)
Nevada (11)
New Hampshire (20)
New Jersey (345)
New Mexico (10)
New York (344)
North Carolina (378)
North Dakota (1)
Northern California (575)
Ohio (50)
Oklahoma (2)
Oregon (8)
Pennsylvania (223)
Puerto Rico (1)
Rhode Island (4)
South America (190)
South Carolina (6)
Southern California (464)
Tennessee (11)
Texas (196)
Utah (41)
Virginia (24)
Washington D.C. (14)
Washington State (117)
West Virginia (2)
Wisconsin (17)
116,235 Results for "c4 imaging".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
C4 Therapeutics to Participate in Upcoming March Investor Conferences
February 24, 2025
·
1 min read
Press Releases
Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - March 4, 2025
March 5, 2025
·
2 min read
Press Releases
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - March 4, 2025
March 5, 2025
·
1 min read
Press Releases
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - March 4, 2025
March 5, 2025
·
1 min read
Press Releases
Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - March 4, 2025
March 5, 2025
·
1 min read
Press Releases
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - March 4, 2025
March 5, 2025
·
2 min read
Press Releases
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - March 4, 2025
March 5, 2025
·
2 min read
Press Releases
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - March 4, 2025
March 5, 2025
·
1 min read
Press Releases
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - March 4, 2025
March 5, 2025
·
1 min read
Sponsored
Sino Biological’s New Center for Bioprocessing (C4B): US-Based CRO Services
In October 2023,
Sino Biological, Inc.
opened its
Center for Bioprocessing (C4B)
in Houston, Texas. The C4B represents a considerable global expansion of the company’s contract research service capabilities.
September 9, 2024
·
3 min read
1 of 11,624
Next
